M. Moubarak

Most-cited papers

1. PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients.

   Thibault Gauduchon, M. Kfoury, D. Lorusso, A. Floquet +16 more

   2023Gynecologic Oncology36 citations Open access

   Semantic Scholar

   Save

2. Implementing HRD Testing in Routine Clinical Practice on Patients with Primary High-Grade Advanced Ovarian Cancer

   F. Heitz, B. Ataseven, C. Staniczok, C. Denkert +11 more

   2023Cancers29 citations Open access

   Semantic Scholar

   Save

3. MRI‐based predictive factors of axillary lymph node status in breast cancer

   D. Atallah, M. Moubarak, W. Arab, N. El Kassis +2 more

   2020The Breast Journal23 citations Open access

   Semantic Scholar

   Save

4. Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience

   M. Moubarak, P. Harter, B. Ataseven, A. Traut +3 more

   2022Gynecologic Oncology Reports20 citations Open access

   Semantic Scholar

   Save

5. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women

   D. Atallah, N. El Kassis, J. Safi, H. El Hachem +2 more

   2021Archives of Gynecology and Obstetrics14 citations

   Semantic Scholar

   Save

6. Long term follow-up after minimally invasive sacrocolpopexy

   N. Khalil, M. Moubarak, M. Alkassis, N. Kassis +2 more

   2022International Urogynecology Journal13 citations

   Semantic Scholar

   Save

7. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary

   T. Westermann, E. Karabeg, F. Heitz, A. Traut +7 more

   2024International Journal of Gynecological Cancer12 citations Open access

   Semantic Scholar

   Save

8. HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer

   Maha Fezza, G. Hilal, R. Tahtouh, M. Moubarak +1 more

   2023ecancermedicalscience11 citations Open access

   Semantic Scholar

   Save

9. The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

   Karolin Heinze, Evan S. Cairns, Shelby Thornton, Bronwyn Harris +24 more

   2023Clinical Cancer Research11 citations Open access

   Semantic Scholar

   Save

10. “You only live twice”: multidisciplinary management of catastrophic case in placenta Accreta Spectrum-a case report

    D. Atallah, H. Abou Zeid, M. Moubarak, M. Moussa +2 more

    2020BMC Pregnancy and Childbirth11 citations Open access

    Semantic Scholar

    Save

11. Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience

    C. Salem, Marie-Ange Hajj, H. Kourie, A. Haddad +5 more

    2020Future Oncology8 citations Open access

    Semantic Scholar

    Save

12. Predictive factors of lymph node metastasis and pattern of repartition in patients with epithelial ovarian cancer.

    D. Atallah, W. Arab, B. Dagher, N. Khalil +6 more

    2021Future Oncology7 citations

    Semantic Scholar

    Save

13. Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status.

    C. Marchetti, B. Ataseven, A. Perrone, C. Cassani +10 more

    2024Gynecologic Oncology5 citations Open access

    Semantic Scholar

    Save

14. Glucose restriction combined with chemotherapy decreases telomere length and cancer antigen-125 secretion in ovarian carcinoma

    S. Antoun, D. Atallah, R. Tahtouh, Mona Diab Assaf +4 more

    2019Oncology Letters5 citations Open access

    Semantic Scholar

    Save

15. Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25

    C. Montégut, C. Falandry, S. Cinieri, C. Cropet +17 more

    2024The Oncologist4 citations Open access

    Semantic Scholar

    Save

16. Molecular tumor board for gynecologic malignancies: the real-world experience from the Department for Gynecology and Gynecologic Oncology of Kliniken Essen-Mitte.

    I. Tsibulak, Rozita Hashemi, J. Welz, M. Moubarak +13 more

    2024International Journal of Gynecological Cancer4 citations

    Semantic Scholar

    Save

17. Does Social and Religious Background Matter? A Study of the Psychosocial Impact of Human Papillomavirus on Lebanese Women

    D. Atallah, Charbel El Feghaly, M. El Feghaly, W. Arab +6 more

    2022Journal of Lower Genital Tract Disease4 citations

    Semantic Scholar

    Save

18. Oncoplastic breast-conservative surgery for breast cancers: a uni-institutional case-control study.

    D. Atallah, W. Arab, N. El Kassis, Emilia Cortbaoui +3 more

    2021Future Oncology4 citations

    Semantic Scholar

    Save

19. Radiomic study of antenatal prediction of severe placenta accreta spectrum from MRI

    Helena C. Bartels, E. Wolsztynski, Jim O'Doherty, D. P. Brophy +11 more

    2024British Journal of Radiology3 citations Open access

    Semantic Scholar

    Save

20. Incidence and Prognostic Impact of Deleterious Germline Mutations in Primary Advanced Ovarian Carcinoma Patients

    M. Imterat, P. Harter, K. Rhiem, F. Heitz +10 more

    2023Cancers3 citations Open access

    Semantic Scholar

    Save

21. Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma

    T. Zwimpfer, S. Fereday, A. Pandey, D. Ariyaratne +144 more

    2026Nature Communications2 citations Open access

    Semantic Scholar

    Save

22. The Lebanese percreta group: A retrospective cohort study of both radical and conservative management outcomes of abnormally invasive placenta

    M. Seoud, R. Chahine, W. Arab, Iman Jaafar +8 more

    2024International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2 citations Open access

    Semantic Scholar

    Save

23. Validation of the Human Papillomavirus Impact Profile in Lebanese Women With Human Papillomavirus or Associated Lesions

    D. Atallah, Charbel El Feghaly, M. El Feghaly, W. Arab +6 more

    2022Journal of Lower Genital Tract Disease2 citations

    Semantic Scholar

    Save

24. Periductal stromal tumor of the breast in a young lady: A case report

    W. Arab, M. Moubarak, Samah Fattah, J. Khazen +3 more

    2021The Breast Journal2 citations Open access

    Semantic Scholar

    Save

25. Breast and tumor volumes on 3D‐MRI and their impact on the performance of a breast conservative surgery (BCS)

    D. Atallah, W. Arab, N. El Kassis, Eliane Nasser Ayoub +3 more

    2020The Breast Journal2 citations Open access

    Semantic Scholar

    Save

26. Accuracy and correlation between intraoperative fresh frozen section result and the final histopathological diagnosis in patients with clinical diagnosis of ovarian cancer (OC) undergoing primary debulking surgery

    L. Neumann, S. Heikaus, P. Harter, E. Thomas +6 more

    2026International Journal of Gynecological Cancer1 citations

    Semantic Scholar

    Save

27. Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

    T. Zwimpfer, S. Fereday, A. Pandey, D. Ariyaratne +144 more

    2025medRxiv1 citations Open access

    Semantic Scholar

    Save

28. Cytoreductive surgery for recurrent platinum-sensitive low-grade ovarian carcinoma: a retrospective single institution experience.

    M. Pruss, M. Bommert, S. Ehmann, F. Temizel-Kanbur +10 more

    2025International Journal of Gynecological Cancer1 citations

    Semantic Scholar

    Save

29. Impact of Age and Body Mass Index on the Outcomes of Laparoscopic Mesh Sacrocolpopexy

    N. Khalil, N. El Kassis, M. Moubarak, C. Chaccour +5 more

    2025Obstetrics and Gynecology International1 citations Open access

    Semantic Scholar

    Save

30. Multidisciplinary management of placenta accreta spectrum in Lebanon: a model for improving outcomes

    H. el Hajj, N. El Kassis, Yara Abdelkhalek, M. Moubarak +1 more

    2024International Journal of Gynecological Cancer1 citations

    Semantic Scholar

    Save

31. #644 Surgical management of FIGO stage IV epithelial ovarian cancer versus FIGO stage IIIC: the real-world experience from KEM

    I. Tsibulak, M. Moubarak, S. Schneider, A. Traut +10 more

    2023Young Ivestigator Session1 citations Open access

    Semantic Scholar

    Save

32. B-Cell Lymphoblastic Lymphoma in Relapse Presenting as a Uterine Mass: A Case Report and Review of Literature

    Rime Abou Chakra, B. Najib, W. Abdallah, M. Akiki +4 more

    2021Case Reports in Oncology1 citations Open access

    Semantic Scholar

    Save

33. 618 Genetic profile by whole exome sequencing of borderline ovarian tumors: series of 32 patients

    D. Atallah, I. El Feghaly, E. Choueiry, N. Jalkh +6 more

    2021Ovarian cancer1 citations Open access

    Semantic Scholar

    Save

34. 313 Modulation of Ca125 expression by htert in ovarian cancer: possible implication of PI3K/Akt/mTOR signaling pathway

    D. Atallah, S. Antoun, M. Moubarak, N. El Kassis +2 more

    2019International Journal of Gynecological Cancer1 citations Open access

    Semantic Scholar

    Save

35. Identification of patients with advanced ovarian cancer (AOC) and high risk for morbidity and mortality undergoing primary therapy in a specialized ESGO certificated tertiary cancer center.

    Florian Heitz, A. du Bois, A. Traut, M. Otiashvili +5 more

    2026International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

36. Sertoli-leydig cell tumors of the ovary: analysis of outcomes and risk factors for recurrence

    H. Plett, P. Harter, D. Krankenberg, A. Strojna +6 more

    2026International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

37. Cytoreductive surgery and prediction of complete resection in advanced low-grade serous ovarian carcinoma: a retrospective single institution experience

    M. Pruss, M. Bommert, S. Ehmann, F. Temizel-Kanbur +11 more

    2026International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

38. Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiative.

    M. Grube, Bianca Ribeiro de Souza, A. Neilson, A. Tinker +50 more

    2026Gynecologic Oncology0 citations Open access

    Semantic Scholar

    Save

39. Fertility‐Sparing Surgery, Treatment Strategies and Survival of Women With Malignant Ovarian Germ Cell Tumours—A Descriptive Analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie CORSETT Database

    Maximilian Klar, M. Moubarak, P. Harter, F. Heitz +16 more

    2026Journal of Surgical Oncology0 citations

    Semantic Scholar

    Save

40. Das Endometriumkarzinom im Wandel

    M. Moubarak, K. Zdanyte, P. Harter

    2026Tumordiagnostik & Therapie0 citations

    Semantic Scholar

    Save

41. Postoperative characteristics of patients with advanced epithelial ovarian cancer admitted to intensive care unit undergoing primary or interval debulking surgery

    M. Bommert, Viviane Stiegler, Wlad Mospanov, H. Groeben +7 more

    2026International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

42. MANAGEMENT IN ADVANCED/RECURRENT CERVICAL CANCER: COMPARING PARAAORTIC LYMPH-NODE INVOLVEMENT AND OLIGO-METASTASIS WITH DISSEMINATED DISEASE - RESULTS FROM THE AGO STUDY GROUP QUALITY ASSURANCE PROGRAM.

    D. Denschlag, M. Moubarak, L. Fangmann, M. Kerkmann +21 more

    2026International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

43. KORE-INNOVATION: main results of a prospective trial of prehabilitation and enhanced recovery after surgery in ovarian cancer patients across two ESGO centers of excellence for surgery in advanced ovarian cancer

    J. Sehouli, Marlene M. Lee, P. Harter, Melisa Gülhan Inci-Turan +16 more

    2026International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

44. The Role Of Cytoreductive Surgery In FIGO IV And Recurrent Endometrial Cancer- A Single Institution Experience

    A. Strojna, M. Moubarak, M. Bommert, S. Ehmann +9 more

    2025International Journal of Gynecological Cancer0 citations Open access

    Semantic Scholar

    Save

45. Molecular Tumor Board For Gynecologic Malignancies: The Real-World Experience From The Department For Gynecology And Gynecologic Oncology Of Kliniken Essen-Mitte

    I. Tsibulak, Rozita Hashemi, K. Zdanyte, M. Moubarak +6 more

    2025International Journal of Gynecological Cancer0 citations Open access

    Semantic Scholar

    Save

46. Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

    D. Garsed, Tibor Zwimpfer, S. Fereday, A. Pandey +144 more

    2025Research Square0 citations Open access

    Semantic Scholar

    Save

47. Cytoreductive surgery for recurrent low-grade ovarian cancer

    P. Harter, M. Moubarak, S. Ehmann, M. Bommert +5 more

    2025Gynecologic Oncology0 citations

    Semantic Scholar

    Save

48. Pelvic Sentinel Lymph Node Mapping In Cervical Cancer: A Single Institution Experience

    S. Ehmann, L. Bennefeld, M. Moubarak, Florian Heitz +7 more

    2025International Journal of Gynecological Cancer0 citations Open access

    Semantic Scholar

    Save

49. A DECADE OF CHANGE - ENDOMETRIAL CARCINOMA (EC) RISK CLASSIFICATION BEFORE, AFTER AND BEYOND TCGA

    C. Fellmann, Annika Rohner, Katharina Knoll, Amy Lum +17 more

    2025International Journal of Gynecological Cancer0 citations

    Semantic Scholar

    Save

50. PR069/#459 Molecular tumor board for gynecologic malignancies: the real-world experience from the department for gynecology and gynecologic oncology of Kliniken Essen-Mitte

    I. Tsibulak, Rozita Hashemi, J. Welz, P. Harter +7 more

    2024Featured Printed Poster Abstracts0 citations Open access

    Semantic Scholar

    Save